Home » Stocks » BioTelemetry

BioTelemetry, Inc. (BEAT)

Stock Price: $42.02 USD -0.73 (-1.71%)
Updated Aug 6, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 1.44B
Revenue (ttm) 412.04M
Net Income (ttm) 19.25M
Shares Out 34.14M
EPS (ttm) 0.53
PE Ratio 79.28
Forward PE 27.47
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 6, 2020
Last Price $42.02
Previous Close $42.75
Change ($) -0.73
Change (%) -1.71%
Day's Open 42.59
Day's Range 41.81 - 42.98
Day's Volume 243,518
52-Week Range 27.35 - 55.85

More Stats

Market Cap 1.44B
Enterprise Value 1.51B
Earnings Date (est) Oct 28, 2020
Ex-Dividend Date n/a
Shares Outstanding 34.14M
Float 28.83M
EPS (basic) 0.57
EPS (diluted) 0.53
FCF / Share 2.02
Dividend n/a
Dividend Yield n/a
Earnings Yield 1.26%
FCF Yield 4.82%
Payout Ratio n/a
Shares Short 2.62M
Short Ratio 7.84
Short % of Float 13.90%
Beta 1.30
PE Ratio 79.28
Forward PE 27.47
P/FCF Ratio 20.75
PS Ratio 3.49
PB Ratio 3.79
Revenue 412.04M
Operating Income 43.41M
Net Income 19.25M
Free Cash Flow 69.24M
Net Cash -74.13M
Net Cash / Share -2.17
Gross Margin 61.28%
Operating Margin 10.53%
Profit Margin 4.40%
FCF Margin 16.80%
ROA 5.14%
ROE 5.27%
ROIC 12.40%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (6)

Buy 5
Overweight 0
Hold 1
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$62.20*
(48.02% upside)
Low
52.0
Current: $42.02
High
80.0
Target: 62.20
*Average 12-month price target from 5 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue439399287208179167130111119120
Revenue Growth9.92%39.3%37.65%16.7%7.16%28.63%16.15%-6.32%-0.75%-
Gross Profit27425017212910793.4679.0765.9069.9572.43
Operating Income52.7549.81-1.7618.019.52-4.31-6.88-13.16-61.32-19.69
Net Income29.8442.82-15.9653.447.43-9.79-7.32-12.20-61.42-19.86
Shares Outstanding33.9532.7130.3927.9227.1226.4425.5424.9324.4324.11
Earnings Per Share0.821.20-0.531.750.26-0.37-0.29-0.49-2.51-0.82
EPS Growth-31.67%--573.08%------
Operating Cash Flow67.5572.7523.7838.8514.358.8111.265.745.0310.36
Capital Expenditures-30.71-24.64-13.70-10.90-13.60-12.78-8.17-5.96-3.95-5.25
Free Cash Flow36.8448.1110.0927.950.75-3.973.09-0.221.085.12
Cash & Equivalents68.6180.8936.0223.0518.9920.0122.1518.3046.4845.48
Total Debt19520020525.4523.5824.740.66---
Net Cash / Debt-127-119-169-2.40-4.60-4.7321.5018.3046.4845.48
Assets68658752519912412487.5590.0194.98157
Liabilities31927627560.0748.2260.7020.7220.0116.9821.76
Book Value36731025113975.9363.6866.8370.0078.00135
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name BioTelemetry, Inc.
Country United States
Employees 1,700
CEO Joseph H. Capper

Stock Information

Ticker Symbol BEAT
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: BEAT
IPO Date March 18, 2008

Description

BioTelemetry, Inc., a remote medical technology company, provides remote cardiac monitoring, remote blood glucose monitoring, centralized core lab services for clinical trials, and original equipment manufacturing services for healthcare and clinical research customers worldwide. It operates in Healthcare, Research, and Corporate and Other segments. The Healthcare segment focuses on the remote cardiac monitoring to identify arrhythmias or heart rhythm disorders. This segment offers mobile cardiac telemetry services; and event monitoring services, which enable physicians to prescribe wireless event, digital loop event, memory loop event, and non-loop event monitors. It also provides Holter and extended-wear Holter monitors, and INR monitoring services. It serves cardiologists, electrophysiologists, neurologists, and primary care physicians. The Research segment offers laboratory services, such as cardiac monitoring, imaging, scientific consulting, and data management services for drug and medical device trials. Its centralized services comprise electrocardiogram, Holter monitoring, ambulatory blood pressure monitoring, echocardiography, multigated acquisition scan, imaging, protocol development, expert reporting, and statistical analysis. It also provides support services, such as project coordination, setup and management, equipment rental, data transfer, processing, analysis, and 24/7 customer support and site training. The Corporate and Other segment focuses on the manufacture, engineering, development, and sale of non-invasive cardiac monitors and other population health management devices for healthcare companies, as well as contract manufacturing services under the BioTel Care and BioTel Alliance names. The company was founded in 1994 and is headquartered in Malvern, Pennsylvania.